These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17998689)

  • 1. Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in the palliative management of non-small cell lung cancer: a prospective randomized study.
    Mallick I; Sharma SC; Behera D; Ghoshal S; Oinam AS
    J Cancer Res Ther; 2006; 2(3):119-25. PubMed ID: 17998689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
    Mallick I; Sharma SC; Behera D
    Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
    Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
    Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience.
    Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R
    Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative endobronchial brachytherapy for non-small cell lung cancer.
    Reveiz L; Rueda JR; Cardona AF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004284. PubMed ID: 23235606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?
    Langendijk JA; Tjwa MK; de Jong JM; ten Velde GP; Wouters EF
    Radiother Oncol; 1998 Nov; 49(2):175-83. PubMed ID: 10052884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer.
    Stout R; Barber P; Burt P; Hopwood P; Swindell R; Hodgetts J; Lomax L
    Radiother Oncol; 2000 Sep; 56(3):323-7. PubMed ID: 10974381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.
    Kelly JF; Delclos ME; Morice RC; Huaringa A; Allen PK; Komaki R
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):697-702. PubMed ID: 11020566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
    Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
    Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review.
    Ung YC; Yu E; Falkson C; Haynes AE; Stys-Norman D; Evans WK;
    Brachytherapy; 2006; 5(3):189-202. PubMed ID: 16864071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF; Horvath J; Peyton W; Ling SS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience.
    Guarnaschelli JN; Jose BO
    J Palliat Med; 2010 Aug; 13(8):981-9. PubMed ID: 20666622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
    Makarewicz R
    Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative endobronchial brachytherapy for non-small cell lung cancer.
    Cardona AF; Reveiz L; Ospina EG; Ospina V; Yepes A
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004284. PubMed ID: 18425900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment.
    de Aquino Gorayeb MM; Gregório MG; de Oliveira EQ; Aisen S; Carvalho Hde A
    Brachytherapy; 2013; 12(5):471-8. PubMed ID: 23541114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical risk factors for early complications after high-dose-rate endobronchial brachytherapy in the palliative treatment of lung cancer.
    Zaric B; Perin B; Jovelic A; Lalic N; Secen N; Kopitovic I; Antonic M
    Clin Lung Cancer; 2010 May; 11(3):182-6. PubMed ID: 20439194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy.
    Muto P; Ravo V; Panelli G; Liguori G; Fraioli G
    Oncologist; 2000; 5(3):209-14. PubMed ID: 10884499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
    Huber RM; Fischer R; Hautmann H; Pöllinger B; Häussinger K; Wendt T
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):533-40. PubMed ID: 9231677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
    Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
    Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.